Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma
Citius Oncology Secures $9 Million to Propel Oncology Pipeline Forward with Strategic Offering
Citius Oncology Secures $9 Million Investment to Propel Growth